Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study

Cancer Medicine

Volumn 7, Issue 9, 2018, Pages 4485-4495

  Baskovic, Mana ^a   Lichtensztajn, Daphne Y ^b   Nguyen, Trung ^a   Karam, Amer ^a   English, Diana P ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Cancer Prevention Institute of California   (United States)

Author keywords

California cancer registry; health disparities in African American populations; high grade uterine cancers; molecular testing in high grade uterine cancer; survival disparity by socioeconomic differences

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; ASIAN; CALIFORNIA; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CARCINOSARCOMA; CAUCASIAN; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE; RACE DIFFERENCE; UTERUS CANCER; UTERUS CARCINOMA; VERY ELDERLY; ETHNIC GROUP; HEALTH DISPARITY; HEALTH SURVEY; MULTIMODALITY CANCER THERAPY; ODDS RATIO; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; COMBINED MODALITY THERAPY; ETHNIC GROUPS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PUBLIC HEALTH SURVEILLANCE; REGISTRIES; SEER PROGRAM; UTERINE NEOPLASMS;

EID: 85053061127     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.1742     Document Type: Article

References (14)

1. Talhouk A, McAlpine JN. New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care. Gynecol Oncol Res Pract. 2016;3:14
2. https://seer.cancer.gov/statfacts/html/corp.html. Accessed January 5, 2018
3. Ries LAG, Eisner MP, Kosary CL, eds, et al. SEER cancer statistics review, 1973–1998. Bethesda, MD: National Cancer Institute; 2001
4. Mahdi H, Hou H, Kowk LL, et al. Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women. Gynecol Oncol. 2014;133(3):512-517
5. Yost K, Perkins C, Cohen R, et al. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703-711
6. Yang J, Schupp C, Harrati A, et al. Developing an area-based socioeconomic measure from American Community Survey data. Fremont, CA: Cancer Prevention Institute of California; 2014
7. Lichtensztajn DY, Giddings BM, Morris CR, et al. Comorbidity index in central cancer registries: the value of hospital discharge data. Clin Epidemiol. 2017;9:601-609
8. Oh SS, Galanter J, Thakur N, et al. Diversity in clinical and biomedical research: a promise yet to be fulfilled. PLoS Med. 2015;12(12):e1001918
9. Chen MS Jr, Lara PN, Dang JH, et al. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials. Cancer. 2014;120(Suppl 7):1091-1096
10. Ayotte BJ, Kressin NR. Race differences in cardiac catheterization: the role of social contextual variables. J Gen Intern Med. 2010;25(8):814-818
11. Alkushi A, Lim P, Coldman A, et al. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int J Gynecol Pathol. 2004;23(2):129-137
12. Maxwell GL, Tian C, Risinger JI, et al. Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy? Cancer. 2008;113(6):1431-1437
13. Guttery DS, Blighe K, Polymeros K, et al. Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas. Oncotarget. 2018;9(24):17093-17103
14. Dubil EA, Tian C, Wang G, et al. Racial disparities in molecular subtypes of endometrial cancer. Gynecol Oncol. 2018;149(1):106-116